356 related articles for article (PubMed ID: 16408263)
21. 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
Acs P; Kipp M; Norkute A; Johann S; Clarner T; Braun A; Berente Z; Komoly S; Beyer C
Glia; 2009 Jun; 57(8):807-14. PubMed ID: 19031445
[TBL] [Abstract][Full Text] [Related]
22. Gene expression in brain during cuprizone-induced demyelination and remyelination.
Morell P; Barrett CV; Mason JL; Toews AD; Hostettler JD; Knapp GW; Matsushima GK
Mol Cell Neurosci; 1998 Nov; 12(4-5):220-7. PubMed ID: 9828087
[TBL] [Abstract][Full Text] [Related]
23. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
Lindner M; Fokuhl J; Linsmeier F; Trebst C; Stangel M
Neurosci Lett; 2009 Apr; 453(2):120-5. PubMed ID: 19356606
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter.
Skuljec J; Gudi V; Ulrich R; Frichert K; Yildiz O; Pul R; Voss EV; Wissel K; Baumgärtner W; Stangel M
J Neuropathol Exp Neurol; 2011 Sep; 70(9):758-69. PubMed ID: 21865884
[TBL] [Abstract][Full Text] [Related]
25. Ultrastructural abnormalities and loss of myelinated fibers in the corpus callosum of demyelinated mice induced by cuprizone.
Xiu Y; Cheng GH; Peng C; Wang Y; Li YD; Chao FL; Tang Y
J Neurosci Res; 2017 Aug; 95(8):1677-1689. PubMed ID: 27935632
[TBL] [Abstract][Full Text] [Related]
26. Probing demyelination and remyelination of the cuprizone mouse model using multimodality MRI.
Wang N; Zhuang J; Wei H; Dibb R; Qi Y; Liu C
J Magn Reson Imaging; 2019 Dec; 50(6):1852-1865. PubMed ID: 31012202
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues.
Plant SR; Wang Y; Vasseur S; Thrash JC; McMahon EJ; Bergstralh DT; Arnett HA; Miller SD; Carson MJ; Iovanna JL; Ting JP
Glia; 2006 Apr; 53(5):529-37. PubMed ID: 16374777
[TBL] [Abstract][Full Text] [Related]
28. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
29. Multicontrast MRI of remyelination in the central nervous system.
Merkler D; Boretius S; Stadelmann C; Ernsting T; Michaelis T; Frahm J; Brück W
NMR Biomed; 2005 Oct; 18(6):395-403. PubMed ID: 16086436
[TBL] [Abstract][Full Text] [Related]
30. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
31. Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice.
Pfeifenbring S; Nessler S; Wegner C; Stadelmann C; Brück W
J Neuropathol Exp Neurol; 2015 Aug; 74(8):756-66. PubMed ID: 26115190
[TBL] [Abstract][Full Text] [Related]
32. Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre.
Mason JL; Langaman C; Morell P; Suzuki K; Matsushima GK
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):50-8. PubMed ID: 11299002
[TBL] [Abstract][Full Text] [Related]
33. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.
Taylor LC; Gilmore W; Ting JP; Matsushima GK
J Neurosci Res; 2010 Feb; 88(2):391-402. PubMed ID: 19746424
[TBL] [Abstract][Full Text] [Related]
34. Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.
Goldberg J; Clarner T; Beyer C; Kipp M
J Mol Neurosci; 2015 Oct; 57(2):166-75. PubMed ID: 26067430
[TBL] [Abstract][Full Text] [Related]
35. Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI.
Boretius S; Escher A; Dallenga T; Wrzos C; Tammer R; Brück W; Nessler S; Frahm J; Stadelmann C
Neuroimage; 2012 Feb; 59(3):2678-88. PubMed ID: 21914485
[TBL] [Abstract][Full Text] [Related]
36. Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach.
Höflich KM; Beyer C; Clarner T; Schmitz C; Nyamoya S; Kipp M; Hochstrasser T
Brain Res; 2016 Nov; 1650():125-133. PubMed ID: 27592741
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of minocycline on cuprizone induced cortical demyelination.
Skripuletz T; Miller E; Moharregh-Khiabani D; Blank A; Pul R; Gudi V; Trebst C; Stangel M
Neurochem Res; 2010 Sep; 35(9):1422-33. PubMed ID: 20544279
[TBL] [Abstract][Full Text] [Related]
38. The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis.
Kipp M; Norkus A; Krauspe B; Clarner T; Berger K; van der Valk P; Amor S; Beyer C
Inflamm Res; 2011 Aug; 60(8):723-6. PubMed ID: 21516513
[TBL] [Abstract][Full Text] [Related]
39. Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging.
Tobin JE; Xie M; Le TQ; Song SK; Armstrong RC
J Neuropathol Exp Neurol; 2011 Feb; 70(2):157-65. PubMed ID: 21343885
[TBL] [Abstract][Full Text] [Related]
40. Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model.
Briggs DT; Martin CB; Ingersoll SA; Barnum SR; Martin BK
Glia; 2007 Nov; 55(14):1405-15. PubMed ID: 17674370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
